Marketing-authorisation holder
IBIGEN Srl
11 medicines in 2 countries, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
11 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMOXICILLINA E ACIDO CLAVULANICO IBIGENPolvere e solvente per soluzione per infusione endovenosa | Amoxicillin, Clavulanic acid | Italy | Authorised | |
| ATOSIBAN IBISQUSConcentrato per soluzione per infusione | Atosiban | Italy | Authorised | |
| BICALUTAMIDE IBIGENCompressa rivestita con film | Bicalutamide | Italy | Authorised | |
| Flucloxacilline Ibisqus 1000 mg poeder voor oplossing voor injectie/infusiePoeder voor oplossing voor injectie of infusie | Flucloxacillin | Netherlands | Authorised | 2017 |
| Flucloxacilline Ibisqus 2000 mg poeder voor oplossing voor injectie/infusiePoeder voor oplossing voor injectie of infusie | Flucloxacillin | Netherlands | Authorised | 2017 |
| Flucloxacilline Ibisqus 250 mg poeder voor oplossing voor injectie/infusiePoeder voor oplossing voor injectie of infusie | Flucloxacillin | Netherlands | Authorised | 2017 |
| Flucloxacilline Ibisqus 500 mg poeder voor oplossing voor injectie/infusiePoeder voor oplossing voor injectie of infusie | Flucloxacillin | Netherlands | Authorised | 2017 |
| IBITAZINAPolvere e solvente per soluzione iniettabile | Piperacillin, Tazobactam | Italy | Authorised | |
| PIPERACILLINA E TAZOBACTAM IBIGENPolvere per soluzione iniettabile/per infusione | Piperacillin, Tazobactam | Italy | Authorised | |
| TEICOPLANINA IBIGENPolvere e solvente per soluzione iniettabile/ per infusione | Teicoplanin | Italy | Authorised | |
| TIROFIBAN IBISQUSSoluzione per infusione | Tirofiban | Italy | Authorised |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Italy | 7 | 7 | 0 | CompaniesAll medicines |
| Netherlands | 4 | 4 | 0 | CompaniesAll medicines |
Also in the registers of United Kingdom
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Antibacterials for systemic useAnti-infectives for systemic use · ATC J01C
- Antithrombotic agentsBlood and blood-forming organs · ATC B01A
- Other gynaecologicalsGenito-urinary system and sex hormones · ATC G02C
- Antibacterials for systemic useAnti-infectives for systemic use · ATC J01X
- Endocrine therapyAntineoplastic and immunomodulating agents · ATC L02B
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- ibigen
- ibigen s r l
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 11
- Countries
- 2
- Roles
- Authorisation holder